- Home
- INO vs NPT Comparison
INO vs NPT Comparison
Compare INO & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | NPT |
|---|---|---|
| Founded | 1979 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.9M | 126.5M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | NPT |
|---|---|---|
| Price | $1.75 | $20.38 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 844.7K | 457.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23,060.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.30 | $3.14 |
| 52 Week High | $2.86 | $22.38 |
Technical Indicators
Market Signals| Indicator | INO | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 90.58 |
| Support Level | $1.72 | $4.42 |
| Resistance Level | $1.78 | N/A |
| Average True Range (ATR) | 0.10 | 1.91 |
| MACD | -0.00 | 1.59 |
| Stochastic Oscillator | 40.13 | 88.43 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.